← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (219)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1454)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis (2026-01-26) ♡
• The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia. (2025/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transforming pulmonary care with applications of endobronchial valves beyond emphysema: a narrative review. (2025/12/31) ♡
• Heterologous Substitution of Mycobacterium tuberculosis rRNA in Mycobacterium smegmatis and Its Impact on Antimicrobial Susceptibility. (2025/12/31) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cannabis sativa in the fight against drug-resistant bacteria and fungi. (2025/12/31) ♡
• Genomic Surveillance of 3R Genes Associated with Antibiotic Resistance in Mycobacterium tuberculosis Isolates from Kazakhstan. (2025/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis: Clinical Laboratory Diagnostic Techniques and Future Perspectives. (2025/12/29) ♡
• Whole Genome Sequencing and Metabolomic Profiling of Six Clinical Mycobacterium Tuberculosis Isolates Reveal Drug Resistance-Associated Features. (2025/12/27) ♡
• Development of machine learning models to identify potentially active compounds against tuberculosis. (2025/12/27) ♡
• Incidence and Spatial Mapping of Tuberculosis and Multidrug-Resistant Tuberculosis in Libreville, Republic of Gabon, in 2022. (2025/12/27) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro Antibiotic Susceptibility of Bacterial Isolates from Polish patients with Cystic Fibrosis: A Non-Interventional Study. (2025/12/26) ♡
• Proteomic Alterations and Antimicrobial Effects of Postbiotics from Probiotic Lactic Acid Bacteria and Yeast Against Multidrug-Resistant Salmonella Typhimurium. (2025/12/25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: a multicountry cohort study. (2025/12/25) ♡
• Nationwide whole-genome sequencing reveals local transmission of Mycobacterium tuberculosis in Poland, 2003-2020. (2025/12/25) ♡
• Data-driven targets for predicting outcomes in patients with HIV infection and tuberculous meningitis in China. (2025/12/25) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Optimal accompanying diagnosis design through external validation of population pharmacokinetic models for moxifloxacin in tuberculosis patients. (2025/12/24) ♡
• Evaluation of tuberculosis education effects on healthcare workers' knowledge attitudes and practices in Jiangsu China 2019 to 2023. (2025/12/24) ♡
• Exploring lived experiences of nurses in managing patients with drug-resistant tuberculosis in Western Amhara, Northwest Ethiopia: a descriptive phenomenological study. (2025/12/23) ♡
• Mycobacterium tuberculosis manipulates LINC02528 in macrophages to modulate anti-tuberculosis metabolic immunity. (2025/12/23) ♡
• Interaction effects of environmental factors with white blood cell profiles on mycobacterial pulmonary diseases: a case-control study. (2025/12/23) ♡
• Magnitude and trends of Mycobacterium tuberculosis: a retrospective cross-sectional study at Hargeisa TB Hospital, Hargeisa, Somaliland. (2025/12/23) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Adverse Drug Reaction to Linezolid in Drug-Resistant Tuberculosis: A Systematic Review. (2025/12/22) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Women's Experiences in the Process of Illness and Care During Tuberculosis Treatment: Systematic Review of a Qualitative Evidence. (2025/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alterations in the Immune Response in Individuals with Latent Tuberculosis Infection. (2025/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis. (2025/12/22) ♡
• Multidrug-Resistant and Extensively Drug-Resistant Skeletal Tuberculosis: Systematic Review of Clinical Profile, Management, and Outcomes. (2025/12/21) ♡
• Risk factors for adverse events in patients with multidrug-resistant tuberculosis, HIV-infection and viral hepatitis C. (2025/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Extensively drug-resistant tuberculosis in Togo: first reported cases and implications for tuberculosis control. (2025/12/17) ♡
• Spatial Analysis of Drug-Resistant Tuberculosis in Colombia (2020-2023): Departmental Rates, Clusters, and Associated Factors. (2025/12/15) ♡
• Expert consensus on the diagnosis and treatment of severe pulmonary tuberculosis. (2025/12/12) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Ending the TB Crisis in Low- and Middle-Income Countries of the Eastern Mediterranean Region-Overcoming Inaction Through Strategical Leaps. (2025/12/12) ♡
• Deciphering the population dynamics and drug-resistance characteristics of extrapulmonary tuberculosis: genomic and clinical insights from a Chinese hospital. (2025/12/11) ♡
• Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024. (2025/12/09) ♡
• Prevalence, risk factors, and rifampicin resistance pattern of Mycobacterium tuberculosis in Sekota town, Northwest Ethiopia. (2025/12/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Two-Front Battle: A Case Report of Pulmonary Tuberculosis and Concurrent Peripheral Neuropathy. (2025/12/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Efficacy and safety of an all-oral delamanid-containing regimen in the treatment of multidrug-resistant pulmonary tuberculosis complicated by extrapulmonary tuberculosis: Four case reports and review of the literature. (2025/12/04) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The critical link between TB infection control process and clinical impact: need for efficacy data and MDR-TB specificity. (2025/12/02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness of FDA vital staining in follow up of DR PTB patients on longer treatment regimen under NTEP. (2025/12/01) ♡
• The performance of rpoB gene mutation linked to rifampicin resistant Mycobacterium tuberculosis isolate from an Indonesian referral hospital. (2025/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis. (2025/12/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Bioequivalence Study of Bedaquiline and Sirturo(®) in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial. (2025/12/01) ♡
• Disk-based method for rapid determination of primary antituberculosis drug susceptibility in Mycobacterium tuberculosis. (2025/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Acceptability of multidrug-resistant tuberculosis preventive treatment: a retrospective survey. (2025/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Rifampicin/Quercetin Nanoemulsions: Co-Encapsulation and In Vitro Biological Assessment Toward Tuberculosis Therapy. (2025/12/01) ♡
• Estimation of second line anti-tubercular drug susceptibility to Mycobacterium tuberculosis in clinical isolates. (2025/12/01) ♡
• Artificial intelligence for screening drug resistance in tuberculosis. (2025/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Barriers to effective management of drug-resistant tuberculosis in India, insights into patient & health system challenges: An exploratory review. (2025/12/01) ♡
• Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis. (2025/12/01) ♡
• Spinal tuberculosis treatment duration: Correlating MRI findings with therapeutic outcomes. (2025/11/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Psoas Abscess From Spinal Tuberculosis Mimicking Appendicitis: A Case Report. (2025/11/22) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.